Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

61.08
+0.88501.47%
Volume:77.62K
Turnover:4.74M
Market Cap:2.12B
PE:-13.48
High:61.93
Open:61.54
Low:60.22
Close:60.19
52wk High:68.73
52wk Low:30.82
Shares:34.77M
Float Shares:28.68M
Volume Ratio:0.36
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5319
EPS(LYR):-3.9613
ROE:-26.36%
ROA:-17.95%
PB:3.46
PE(LYR):-15.42

Loading ...

Disc Medicine Inc - Expects Initial Data From From Phase 2 Study of Disc-0974 in Q4 2025

THOMSON REUTERS
·
Aug 07

Disc Medicine Inc - on Track to Submit Nda for Bitopertin in October 2025

THOMSON REUTERS
·
Aug 07

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 07

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025

Dow Jones
·
Aug 07

Director Kevin Bitterman Reports Disposal of Common Shares of Disc Medicine Inc. i

Reuters
·
Aug 02

FDA Accelerated Pathway Feedback on Bitopertin Might Change the Case for Investing in Disc Medicine (IRON)

Simply Wall St.
·
Jul 30

Press Release: CHAMPION IRON REPORTS ITS FY2026 FIRST QUARTER RESULTS, AND ADVANCES THE DRPF PROJECT AS SCHEDULED

Dow Jones
·
Jul 30

Director’s Major Stock Sale Shakes Up Disc Medicine!

TIPRANKS
·
Jul 26

Director Kevin Bitterman Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Jul 26

Disc Medicine Director Makes a Strategic Stock Move

TIPRANKS
·
Jul 23

Director Kevin Bitterman Reports Disposal of Common Shares in Disc Medicine Inc

Reuters
·
Jul 23

Truist Securities Initiates Coverage on Disc Medicine With Buy Rating, $86 Price Target

MT Newswires Live
·
Jul 21

Disc Medicine Inc. Announces Positive Pre-NDA Meeting with FDA and Plans to Submit NDA for Bitopertin in October 2025

Reuters
·
Jul 21

CFO Jean M. Franchi Reports Disposal of Common Shares in Disc Medicine Inc

Reuters
·
Jul 19

Raymond James Reaffirms Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
Jul 19

Buy Rating for Disc Medicine: DISC-0974’s Potential in Myelofibrosis-Related Anemia

TIPRANKS
·
Jul 19

Disc Medicine Inc. Files Initial Beneficial Ownership Statement for Director Nadim Ahmed

Reuters
·
Jul 17

Jean M. Franchi, CFO, Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Jul 15

Disc Medicine appoints Ahmed to its Board of Directors

TIPRANKS
·
Jul 14

Disc Medicine Inc. Appoints Nadim Ahmed to Board of Directors Amid Strategic Growth Initiatives

Reuters
·
Jul 14